A mathematical optimal-control tumor therapy framework consisting of radio-and anti-angiogenesis control strategies that are included in a tumor growth model is investigated. The governing system, resulting from the combination of two well established models, represents the differential constraint of a non-smooth optimal control problem that aims at reducing the volume of the tumor while keeping the radio-and anti-angiogenesis chemical dosage to a minimum. Existence of optimal solutions is proved and necessary conditions are formulated in terms of the Pontryagin maximum principle. Based on this principle, a so-called sequential quadratic Hamiltonian (SQH) method is discussed and benchmarked with an "interior point optimizer-a mathematical programming language" (IPOPT-AMPL) algorithm. Results of numerical experiments are presented that successfully validate the SQH solution scheme. Further, it is shown how to choose the optimisation weights in order to obtain treatment functions that successfully reduce the tumor volume to zero.
Introduction
Cancer has a growing impact on our society, because it is among the main causes of illness and death worldwide. On account of this, there exist many treatment options as surgery, chemotherapy, radiation therapy, hormonal therapy, immunotherapy and anti-angiogenic treatment. For all these therapies, it is important to balance the benefits of each treatment with its negative side effects. Therefore a natural mathematical approach to cancer therapy is to consider a mathematical model of the time evolution of tumor that includes the action of the therapy as a control mechanism with the purpose to minimize the tumor volume, while keeping at a minimum the negative side effects on the healthy cells. In order to find an optimal therapy, we formulate an optimal control problem that requires to minimize the tumor volume in a given time horizon and to maximize the health-related quality of life of the patient.
Concerning previous works on optimal control in drug therapy, we refer to, e.g., [1] [2] [3] . However, while these references discuss models for immunotherapy, the combination of radiation therapy and anti-angiogenic treatment as in [4] and in our work is not considered. Another new aspect of our cancer therapy model is the combination of two tumor growth systems, one proposed by Hahnfeld et al. [5] and the other one by Ergun et al. [6] . We discuss our model in Section 2, where we illustrate the inclusion of control mechanisms and provide values of the model's parameters that result from real data.
The typical optimization objective used in cancer therapy models that are considered in the literature is to minimize the tumor volume at the terminal time; see [3] and [4] . In this paper, we investigate a more general cost functional that corresponds to minimizing the tumor volume along the entire time horizon and including L 1 -and L 2 -costs of the treatment modelled by the control functions. In Section 2.3, we discuss this new cost functional and formulate our optimal control problem. In Section 3, we provide a detailed analysis of our tumor development and treatment model and discuss equilibrium points of this dynamical system and the positivity of solutions. In Section 4, we prove existence of optimal solutions to our optimal control problem and their characterization by the optimality conditions in the framework of the Pontryagin maximum principle (PMP). In Section 5, we illustrate the sequential quadratic Hamiltonian (SQH) method. Also in this section, we consider the operating mode of the "interior point optimizer-a mathematical programming language" (IPOPT-AMPL) solver that we use as a benchmark for our optimization method, before we focus on our SQH scheme. In Section 6, we present results of numerical experiments that successfully validate the effectiveness of our numerical optimization procedure that computes the same results as the IPOPT-AMPL scheme, while requiring considerably less time. Further, we use our SQH solution scheme to show that it is possible to set the optimisation weights in such a way to obtain treatment functions that successfully reduce the tumor volume to zero. A section of conclusion completes this work.
Mathematical Modeling of Cancer Development and Treatment
We investigate a new mathematical model for cancer development and treatment resulting from a combination of two complementary mathematical models. Both 
Next, we consider a time-varying carrying capacity q. The basic idea is a combination of stimulatory (S) and inhibitory (I) effects as follows
A modelling issue is the choice of S and I, and for this reason we consider the model proposed by Hahnfeldt et al. [5] as follows 2 3 , q bp dp q = −  (2) with the birth rate 0 b > and the death rate 0 d > . This is a well-recognized mathematical model for time-varying carrying capacity. However, it couples the tumor volume variable to the carrying capacity.
On the other hand, a model of time-varying carrying capacity that does not involve the tumor volume explicitly is due to Ergun et al. [6] . This model is computationally convenient since p does not appear in the equation. We have
Based on validation with real data [5] [6], both models appear promising in the quest of an accurate description of tumor growth. For this reason, we consider a combination of the two models (2) and (3) as follows ( ) 2  4  2  3  3  3 1 , q bq dq bp dp q
Together with the equation for the tumor growth (1), we obtain the following differential system that models the evolution of the tumor volume and of the carrying capacity of the vasculature. We have ( ) 2  4  2  3  3  3 ln , 1 . p p p q bq dq bp dpIn Figure 1 , we show the evolution of this system for initial values with In the next two sections, we introduce two control mechanisms in (4) that represent the treatment of cancer by anti-angiogenesis and radiotherapy, respectively [3] .
Anti-Angiogenesis
The angiogenesis is a process where a growing tumor develops its own blood vessels, which provide the tumor with oxygen and nutrients. The anti-angiogenesis 1 . q bq dq bp dpu 
The anti-angiogenic treatment influences the carrying capacity of the vascularity q, but as q appears in the equation for p, it also influences the tumor volume p.
Radiotherapy
Radiotherapy is a treatment that uses ionizing radiation to kill cancer cells. For this purpose and to minimize damage on healthy tissues the tumor should be well localized. [7] , the damage that is done to the tumor by radiation is modelled as fol- 
This model is completely specified by giving the values of the parameters appearing in it. These values are specified in Table 1 ; see [6] and [8] .
The Optimal Control-Treatment Problem
Usually, in the context of optimal control of cancer development models, the objective of the control is to minimize the volume of the tumor at final time, i.e. We define our optimal control problem with anti-angiogenesis and radiotherapy as follows ( ) 
with the initial conditions ( ) σ ϑ ν µ ν µ ≥ can be chosen differently to obtain different settings. We refer to this optimal control problem as the (OCAR3) control problem. Notice that in [9] a similar model is considered where only the tumor volume at the final time enters in the controls' objective.
Analysis of the Anti-Angiogenesis and Radio-Therapy Model
In this section, we analyse our cancer development and treatment differential system in (OCAR3). We have the following lemma. 
From the second equation with q p = , we obtain 2 2 2 2 3 3 3 3 0 0 0 0. p b dp p b dp p q b dp
To show that the equilibrium point ( ) 
, ,
For this system, we denote the equilibrium point with ( ) 
We have that the trace is 
Next, we consider the uncontrolled case with 1 κ = and neglect the equation for r since in this case r is not coupled to the ( ) 
, .
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E νω is strictly increasing for fixed r with ( ) κ ∈ . The model is well defined and by applying Caratheodory's Theorem (see for example [10] , Theorem 54 Proposition C.3.6) one can show existence and uniqueness of a solution to (6).
Optimal Solutions and the Pontryagin Maximum Principle
In this section, we discuss existence of optimal controls and their characterization by optimality conditions.
The existence of an optimal solution to the (OCAR3) control problem can be shown as follows. We know that all solutions 
, , x u w J x u w  is convex and continuous (see [12] Theorem 2.14) and thus weakly lower semicontinuous (see [11] Theorem 2.12). Therefore we apply the direct method in calculus of variation and obtain the existence of an optimal solution to our problem (OCAR3).
Next, we discuss the characterization of optimal solutions in the framework of 3) The controlled dynamical system ( )
is given by the function
. We assume that the partial derivative 
⋅ is called admissible if it is a solution to the differential Equation (11) and if ( )
The objective of the control u ∈  is to minimize the following functional
, and the derivative with respect to x is continuous.
Our optimal control problem is now given as follows
T J x u L s x s u s s g x T x f t x t u t x x u t U t T
Notice that the optimal control problem (OCAR3) that was introduced in Section 1 is of this form.
Definition 2 The Hamiltonian function :
 for the optimal control problem (12) is defined as follows By applying PMP to our optimal control problem (OCAR3), we obtain the following necessary conditions for an optimal solution. 
with the terminal conditions ( ) ( )
Numerical Optimization
In this section, we deal with the numerical implementation of our control framework that belongs to the class of optimize-before-discretize methods. However, in the case of a discretize-before-optimize approach, one could consider the method proposed in [15] . In the first part of this section, we introduce our optimization scheme. In the second part, we refer to the operating mode of the IPOPT solver that we use together with the programming language AMPL for benchmarking our SQH scheme.
The main idea of the SQH scheme is the straightforward pointwise minimization of the Hamiltonian function in a way that has been first proposed in [16] [17]. Notice that, in this approach, the pointwise update of the control is performed on all grid points and only thereafter the corresponding state is computed. However, this pointwise update of the control may result in large changes of the value of the state variable that makes the proposed approach less robust.
This problem is also discussed in [16] where this issue is left open. On the other hand, we have the quadratic regularisation method proposed in [18] , where the Hamiltonian function is augmented with a weighted quadratic term that penalizes deviations from the previous control value to keep the updates of the control sufficiently small. Further, in [18] every pointwise update of the control is followed by a global update of the state variable, which makes this approach very time consuming. In the SQH scheme, we combine the advantages of the two schemes performing a pointwise update of the augmented Hamiltonian on all grid points and recalculating the state variable after the control update. The augmented Hamiltonian is given by
, , , , , , ,ˆ:
, , , , , , ,
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We remark that by increasing  a sufficient descent of the cost functional in each iteration can be achieved, see ([19] , Lemma 4.1).
While we refer to [19] for a detailed analysis of convergence of the SQH scheme, in the following algorithm we present the implementation of this method. For this purpose, we denote
Algorithm 1 (SQH method) We remark that the update of ( ) 
To benchmark our novel method with a well-known solution scheme, we remark that the numerical approximation of an optimal control problem as (OCAR3)
can interpreted as a nonlinear optimization problem that can be solved by using a nonlinear programming approach; see, e.g., [20] . The way we choose to perform this task is by using the modeling language AMPL [21] and the solver IPOPT [22] .
We refer to the resulting optimization framework as the IPOPT-AMPL solver.
Numerical Experiments
This section is devoted to the investigation of the effectiveness of our numerical In Table 2 In Table 3, Figure 3 .
Since the value of the control u at the beginning is bigger than in the first experimental setting, the states p and q are initially decreasing faster than before.
The tumor volume reduces to ( ) 15.1133 p T = , which is smaller than in the first setting, but now the carrying capacity of the vasculature is larger with ( ) 518.716
q T = , so again the tumor will grow after the treatment. As above,
IPOPT-AMPL provides a comparable solution and the results presented in Table 4 also confirm this fact. Again the computation time for the SQH method is less than the one needed by IPOPT.
In the experiments above, our focus was the comparison of the SQH method with the IPOPT-AMPL scheme. For this reason, less attention has been put on the ability of our optimal control formulation to deliver effective treatment. In the following experiments, we would like to show that it is indeed possible to find an optimisation setting that results in control functions that are able to reduce the volume and carrying capacity to zero at final time. In particular, we
show the importance of the L 1 -cost towards this task.
Indeed, control costs of L 1 -type are considered in the literature for their ability to promote sparsity of controls. However, this feature is usually validated with a single control function, whereas in our case two control functions are considered that act on a nonlinear coupled system. In fact, as results of our experiment show, the choice of the weights of the costs of the control is a delicate issue.
For our experiments, we choose a time horizon 7 T = (7 days), and the following control bounds max 10 u = To determine these therapies, an optimal control problem was formulated considering a cost functional including the tumor volume and L 1 -and L 2 -penalty terms for the controls. After the proof of existence of minimizers, the necessary optimality conditions that characterize these minimizers were deduced in the framework of the Pontryagin maximum principle. Based on this PMP framework, the SQH method was used for numerical solution. This algorithm was used to solve the optimal cancer therapy problem with different experimental settings. Furthermore, optimal solutions obtained by the SQH algorithm were compared with the optimal solution obtained by the IPOPT solver together with the programming language AMPL. This comparison showed that the SQH method is faster by a factor 10 than IPOPT. In a final series of experiments it was shown that it is actually possible to choose the optimisation parameters in such a way to reduce the volume of the tumor and the related carrying capacity to zero.
